Tyrez tablets film-coated

País: Armenia

Idioma: inglés

Fuente: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes activos:

bisoprolol (bisoprolol fumarate)

Disponible desde:

Alkaloid AD Skopje

Código ATC:

C07AB07

Designación común internacional (DCI):

bisoprolol (bisoprolol fumarate)

Dosis:

2,5mg

formulario farmacéutico:

tablets film-coated

Unidades en paquete:

(30/3x10/) in blister

tipo de receta:

Prescription

Estado de Autorización:

Registered

Fecha de autorización:

2017-11-30

Ficha técnica

_( _
~
-::T_Y
_
R_I2_
{ _
})
2
7
.S:::-n....::lg
7
,
_5
_m~g,-a_nd
__
I
O-:-m--.::gc-li-tl_nl_-co
__
a
l_
c
d_ta_b
_l_et
_s
-
-----
-
------=-
A
~
LKALO
1
D
Summary
of
Pr
od
ll
ct Characteristics
sкoP..t
O!
SUMMARY
OF
PRODUCT
CHARACTERJSTICS
1.
NAME
OF
ТНЕ
MEDICJNAL
PRODUCT
TYREz® 2.5 mg film-coated
taЬiets
TYREZ
Ф
_5 _
mg film-coated
taЬiet
s
TYREZ®
1
О
mg film-coated
taЫets
2.
QUALIТATIVE
AND
QUANТITATfVE
COМPOSITION
TYREZ 2.5 mg
film-
coated
taЫets:
Eac
l1
film-coated
taЫet
co
ntains 2.5 mg
of
Ьisoprolol
ft
rm
arate
TYREZ
_5 _
mg film-coated
taЬiets:
Eac
l1
film-coated
taЬiet
contains _5 _
mg
ofbl
soprolol
fшnarate
TYREZ
1
О
mg film-coated
taЬiets:
Each
fi
lm-coated
taЫet
contains
10
mg
ofblsoprolol
fumaгate
For
the full
li
st
of
excipients, see section
6.1
.
1
а
1
L
3.
PHARМACEUTICAL
FORM
Fi
lm-coat
ed
taЬiet.
TYREZ 2.5 mg film-coated
taЫets
are
wl1ite,
round,
Ьiconvex
,
film-coated
taЬi
e
ts
witl1
Ьi
s
ectio11
lin
e
on
one side. The
taЬiet
сап Ье
divided
into
equal doses.
TYREZ
_5 _
mg filrn-coated
taЫets
are yellow,
r·ound
,
Ьiconvex
,
film-coated
taЬiets
witl1
Ьisecti
o
п
lin
e
on
one si
de.
The
taЫet
са
п
Ье
divided into equal doses.
TYREZ
10
mg
film-coated
t
aЬiets
are ochre yellow,
roнnd
,
Ьiconvex
,
film-coated
taЫet
s
witl1
Ьisection
line on one s
ide.
The
taЬiet
сап
Ье
divided into equal dose
s.
4.
CLINICAL
PARТICULARS
4.1
Therapeutic
indications
1-lypertension
Angina pectoris
(@)
_
T
_Y_R
_
~
_
z®
__
2_.5~•n~g~,_5_n~
,g
~a_n_d_
I
_
O
~
m~
g
_
П
_
tlm
__
-c
_oa_
te
_d_t
_a
b_l_et_
s
__________________
______
~~~L
s~~~~~·D
S
ttn1mary
ol· Product
C
l
шract
e
ristic
s
T
г
eat
ment
of
staЫe
cl
1ronic heart failtJre with reduced systolic left ventricul
ar
function
iп
addition to
АСЕ
inhibltors, and diur
et
ics, and optiona
ll
y digitalis glycosides
(for
additional
in
formati
oп
see
section 5. 1
).
Ту
г
еz
is
iпdicated
for
the treatment
of
adults.
4.2
Posology
and
anetlaod
of
adшinistration
~
..•
=-.т,~
_dct _
jм
,
_;o.--t